Oculis Holding AG (OCS) Intangibles (2021 - 2026)
Oculis Holding AG's (OCS) quarterly Intangibles came in at $17.0 million in Q1 2026, up 14.81% year-on-year from $14.8 million in Q1 2025, and up 2.06% quarter-over-quarter from $16.6 million in Q4 2025.
Oculis Holding AG (OCS) Intangibles (2021 - 2026) Analysis & Trends
Oculis Holding AG's Intangibles history runs 6 years deep, the most recent figure standing at $17.0 million for Q1 2026.
- On a quarterly basis, Intangibles rose 14.81% year-over-year to $17.0 million in Q1 2026; TTM through Mar 2026 was $17.0 million, a 14.81% increase from a year earlier, with the FY2025 full-year figure at $16.0 million, up 6.11% from the prior year.
- Intangibles improved to $17.0 million in Q1 2026 per OCS's latest filing, from $16.6 million in the prior quarter.
- Across five years, Intangibles topped out at $17.0 million in Q1 2026 and bottomed at $12.7 million in Q4 2022.
- The 5-year median for Intangibles is $14.1 million (2024), against an average of $14.7 million.
- Across the five-year window, Intangibles jumped 33.92% in 2022 and dropped 0.57% in 2024, its largest moves.
- Year by year, Intangibles stood at $12.7 million in 2022, then gained by 8.61% to $13.8 million in 2023, then advanced by 10.27% to $15.2 million in 2024, then increased by 9.61% to $16.6 million in 2025, then gained by 2.06% to $17.0 million in 2026.
- Per Business Quant, the three latest OCS Intangibles figures stand at $17.0 million (Q1 2026), $16.6 million (Q4 2025), and $16.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.97 Mn |
| Dec 31, 2025 | 16.63 Mn |
| Sep 30, 2025 | 16.62 Mn |
| Jun 30, 2025 | 16.06 Mn |
| Mar 31, 2025 | 14.78 Mn |
| Dec 31, 2024 | 15.17 Mn |
| Sep 30, 2024 | 14.09 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 13.98 Mn |
| Dec 31, 2023 | 13.76 Mn |
| Sep 30, 2023 | 13.82 Mn |
| Jun 30, 2023 | 13.58 Mn |
| Dec 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 9.46 Mn |